このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

APT Medical 将来の成長

Future 基準チェック /66

APT Medical利益と収益がそれぞれ年間27.4%と27.2%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に29.1% 24.3%なると予測されています。

主要情報

27.7%

収益成長率

24.6%

EPS成長率

Medical Equipment 収益成長	22.4%
収益成長率	27.3%
将来の株主資本利益率	28.2%
アナリストカバレッジ	Low
最終更新日	26 Jun 2024

今後の成長に関する最新情報

Recent updates

Are APT Medical Inc. (SHSE:688617) Investors Paying Above The Intrinsic Value?

Jun 20

APT Medical Inc. (SHSE:688617) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

May 10

APT Medical's (SHSE:688617) Promising Earnings May Rest On Soft Foundations

May 02

APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively

Apr 10

Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today

Mar 19

業績と収益の成長予測

SHSE:688617 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	3,776	1,240	N/A	948	3
12/31/2025	2,951	951	N/A	1,107	5
12/31/2024	2,200	703	N/A	590	4
3/31/2024	1,756	571	389	687	N/A
12/31/2023	1,650	534	487	689	N/A
9/30/2023	1,542	501	404	572	N/A
6/30/2023	1,448	457	352	519	N/A
3/31/2023	1,300	394	267	417	N/A
12/31/2022	1,216	358	224	367	N/A
9/30/2022	1,123	306	197	371	N/A
6/30/2022	1,000	252	103	250	N/A
3/31/2022	933	228	40	206	N/A
12/31/2021	829	208	14	181	N/A
9/30/2021	750	201	39	164	N/A
6/30/2021	671	186	119	223	N/A
3/31/2021	569	149	139	200	N/A
12/31/2020	479	111	104	148	N/A
9/30/2020	442	93	61	110	N/A
12/31/2019	404	83	-13	55	N/A
12/31/2018	242	22	-14	19	N/A
12/31/2017	153	34	N/A	13	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 688617の予測収益成長率 (年間27.4% ) は貯蓄率 ( 2.9% ) を上回っています。

収益対市場: 688617の収益 ( 27.4% ) はCN市場 ( 22.7% ) よりも速いペースで成長すると予測されています。

高成長収益: 688617の収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: 688617の収益 ( 27.2% ) CN市場 ( 13.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: 688617の収益 ( 27.2% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 688617の自己資本利益率は、3年後には高くなると予測されています ( 29.1 %)

APT Medical 将来の成長

Future 基準チェック /66

主要情報

今後の成長に関する最新情報

Price target increased by 10% to CN¥497

Consensus EPS estimates fall by 30%

Price target decreased to CN¥281

Consensus forecasts updated

Recent updates

APT Medical Inc. to Report First Half, 2024 Results on Aug 23, 2024

Are APT Medical Inc. (SHSE:688617) Investors Paying Above The Intrinsic Value?

APT Medical Inc., Annual General Meeting, Jun 27, 2024

APT Medical Inc. (SHSE:688617) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

APT Medical's (SHSE:688617) Promising Earnings May Rest On Soft Foundations

Price target increased by 10% to CN¥497

First quarter 2024 earnings released: EPS: CN¥2.10 (vs CN¥1.54 in 1Q 2023)

Shenzhen Mindray Technology Holdings Co., Ltd. completed the acquisition of 19.72% stake in APT Medical Inc. (SHSE:688617) from group of sellers.

APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively

Consensus EPS estimates fall by 30%

APT Medical Inc. to Report Q1, 2024 Results on Apr 26, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today

Full year 2023 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: CN¥2.18 (vs CN¥1.53 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥2.32 (vs CN¥1.38 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2022 earnings released: EPS: CN¥5.37 (vs CN¥3.19 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥1.53 (vs CN¥0.71 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

APT Medical Inc. (SHSE:688617) announces an Equity Buyback for CNY 100 million worth of its shares.

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Price target decreased to CN¥281

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Consensus forecasts updated

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2021 earnings released: EPS CN¥0.71 (vs CN¥0.63 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥1.02 (vs CN¥0.63 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.77 (vs CN¥0.43 in 1Q 2020)

APT Medical Inc. to Report Fiscal Year 2020 Results on Apr 27, 2021

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘